Drug Genius | Prescription Drug Information: Side Effects, Dosage & Interactions

Global Hydroxychloroquine Market is estimated to be US$ 2.7 Billion by 2029 with a CAGR of 5.3% during the Forecast Period - PMI

CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next

Jun 11, 2020

RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib

Jun 10, 2020

Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021

Jun 09, 2020

Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital

Jun 08, 2020

RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference

Jun 08, 2020

CytoDyn Receives BLA Acknowledgment Letter From the FDA

Jun 08, 2020

Medication

Sildenafil - Uses, Side Effects, Dosage & Interactions

Generic Name: Sildenafil, Sildenafil citrate Brands: Viagra, Revatio Class: Phosphodiesterase-5 (PDE5) inhibitors Availability: Prescription only Molecular Formula: C28H38N6O11S Substance…

View Post

Conditions

Anemia

Also called: Low red blood cell count Low hemoglobin The Centers for Disease Control and Prevention states that…

Conditions

Bronchitis

Also called: Acute bronchitis Chest cold Common cold Chronic bronchitis/COPD (chronic bronchitis is a form of…

Conditions

Pancreatitis

Also called: inflammation of the pancreas Data indicates that cases of acute pancreatitis are becoming more…

Global Hydroxychloroquine Market is estimated to be US$ 2.7 Billion by 2029 with a CAGR of 5.3% during the Forecast Period - PMI

Polydex Pharmaceuticals Issues First Quarter Financial Results

Phathom Pharmaceuticals Provides Clinical Trial Status Update

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next

RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib

Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021

Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital

RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference

CytoDyn Receives BLA Acknowledgment Letter From the FDA

Sildenafil - Uses, Side Effects, Dosage & Interactions

Anemia

Bronchitis

Pancreatitis

Latest News

MaaT Pharma Appoints Claude Bertrand, Servier’s Executive Vice President of R&D, as Independent Board Member and Welcomes New Chief Medical Officer John Weinberg

Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020

FDA Grants Priority Review to Merck’s New Drug Application for Vericiguat

New Preclinical Study Finds Niagen® Corrects Social Deficits in Mouse Model of Autism

Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers

FDA Approves Data Streaming from the Impella Console, Setting the Stage for Artificial Intelligence Algorithms to Further Improve Patient Outcomes

Popular Now

Famotidine for Dogs - Dosage, Side Effects, Is It Safe?

Rejection Sensitive Dysphoria - Symptoms, Causes & Diagnosis

Accutane Results - Before and After Isotretinoin Photos

Lion's Mane Mushroom - Uses, Benefits, and Side Effects

Cluster B Personality Disorders - Traits, Causes & Treatment

Pressured Speech and Bipolar Disorder